Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 5/20 | 0.54 |
| ▸ | MDM4 | O15151 | 3/20 | 0.53 |
| ▸ | TP53 | P04637 | 3/20 | 0.53 |
| ▸ | SIRT2 | Q8IXJ6 | 12/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17991594 | 1.00 | MDM2 (0.54) | MDM2MDM4TP53SIRT2 | |
| SCHEMBL1737899 | 0.93 | MDM4 (0.54) | MDM2MDM4TP53SIRT2 | |
| SCHEMBL13227674 | 0.93 | MDM4 (0.54) | MDM2MDM4TP53SIRT2 | |
| SCHEMBL12994493 | 0.93 | MDM4 (0.54) | MDM2MDM4TP53SIRT2 | |
| SCHEMBL29368020 | 0.93 | MDM4 (0.54) | MDM2MDM4TP53SIRT2 | |
| SCHEMBL30433831 | 0.93 | MDM4 (0.54) | MDM2MDM4TP53SIRT2 | |
| SCHEMBL28625949 | 0.92 | MDM2 (0.52) | MDM2MDM4TP53SIRT2 | |
| SCHEMBL28625947 | 0.92 | MDM2 (0.52) | MDM2MDM4TP53SIRT2 | |
| SCHEMBL30434660 | 0.92 | MDM2 (0.52) | MDM2MDM4TP53SIRT2 | |
| SCHEMBL30468161 | 0.90 | SIRT2 (0.55) | MDM2MDM4TP53SIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12415835-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-16 | — | — | US | disclosed |
| US-12227542-B2 | Method for producing peptide compound, protective group-forming reagent, and condensed polycyclic compound | FUJIFILM CORPORATION (JP) | 2025-02-18 | — | — | US | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-11891457-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-02-06 | — | — | US | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-110922452-B | Method for synthesizing goserelin | 深圳翰宇药业股份有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-110922453-B | Method for synthesizing goserelin | 深圳翰宇药业股份有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| EP-3992187-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, REAGENT FOR FORMING PROTECTIVE GROUP, AND FUSED POLYCYCLIC COMPOUND | FUJIFILM Corporation (JP) | 2022-05-04 | — | — | EP | disclosed |
| US-20220112234-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC COMPOUND | FUJIFILM CORPORATION (JP) | 2022-04-14 | — | — | US | disclosed |
| EP-3974563-A1 | CYCLIC PEPTIDES | Chugai Seiyaku Kabushiki Kaisha (JP) | 2022-03-30 | — | — | EP | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12227542-B2 | Method for producing peptide compound, protective group-forming reagent, and condensed polycyclic compound | C9, GRPR, VIP | MDM2 1622/4885MDM4 3663/4885TP53 2041/4885 |
| US-11891457-B2 | Peptide-compound cyclization method | VIP, NGLY1, GLP1R | MDM2 2401/4885MDM4 3559/4885TP53 2654/4885 |
| US-20220112234-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC COMPOUND | C9, GRPR, VIP | MDM2 1622/4885MDM4 3663/4885TP53 2041/4885 |
| US-12415835-B2 | Peptide-compound cyclization method | VIP, NGLY1, GLP1R | MDM2 2401/4885MDM4 3559/4885TP53 2654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.